Training activity information

Details

Respond to clinical queries/ significant results related to the diagnosis and management of infection in people with poorly-controlled HIV.

To include selection and interpretation of relevant tests and drafting of advice.

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

  • What specific knowledge about common opportunistic pathogens, relevant serological and molecular tests, and the importance of CD4 counts do you need to review?
  • What specific insights into the range of infections affecting individuals with advanced HIV and the role of the laboratory in their diagnosis and monitoring do you hope to gain? What is your current understanding of the relationship between viral load, CD4 count, and susceptibility to infection?
  • Have you discussed typical clinical scenarios and queries related to infections in patients with poorly controlled HIV with your training officer? What challenges might you face in interpreting complex immunological and virological data? How will you approach these? What are your feelings about working with cases involving individuals with HIV?

In action

  • What is your immediate approach to the clinical query or significant result for a patient with poorly-controlled HIV?
    • What key considerations related to their immunocompromised state are you prioritising?
    • What crucial decisions are you making regarding the breadth of potential investigations for opportunistic infections, the interpretation of results that might indicate unusual pathogens, and the formulation of management advice that considers their underlying HIV status and potential drug interactions?
    • What aspects of responding to common infections feel similar, and where do you need to be particularly alert for opportunistic pathogens and atypical presentations in this context?
  • How well do you believe your current approach is addressing the potential range of infections in this immunocompromised patient?
    • What specific challenges are you encountering due to the patient’s poorly-controlled HIV?
    • What are you learning about the types of opportunistic infections that can occur and the importance of considering these in the differential diagnosis?
    • How does this activity connect to your understanding of HIV pathogenesis, the spectrum of opportunistic infections, and the importance of multidisciplinary care?
  • Are you considering a wider range of diagnostic tests than you might for an immunocompetent patient with similar symptoms?
    • Do you recognise the importance of collaborating with infectious disease specialists or HIV physicians in these cases?
    • Are you ensuring your advice considers potential interactions with antiretroviral therapy and the overall management of the patient’s HIV?

On action

  • Begin by summarising the key points of the experience of responding to clinical queries/significant results for individuals with poorly-controlled HIV and suspected opportunistic infections.
  • What skills or knowledge did you develop or improve related to the spectrum of opportunistic infections seen in individuals with advanced HIV and the appropriate diagnostic strategies?
    • Were there any unexpected challenges or successes in interpreting results that might indicate specific opportunistic pathogens?
    • What did you learn from these? In what ways did your reflection-in-action (during the activity) influence your recommendations for specific investigations and management strategies, considering the patient’s immunocompromised state?
    • How does this experience relate to the requirements for post-programme practice in providing specialist microbiology input for the care of individuals with HIV?
  • What areas for continued development have been identified in responding to clinical queries for infections in people with poorly-controlled HIV?
    • How can you apply the learning from this activity to your routine practice, particularly in understanding the importance of considering opportunistic infections in the differential diagnosis and the role of the HIV multidisciplinary team?
    • Identify the actions / ‘next steps’ you will now take to support the assimilation of what you have learned, such as reviewing guidelines on opportunistic infections in HIV or discussing cases with HIV physicians.
    • What support or resources might you need to further develop your skills in this area, such as attending HIV infection conferences or reviewing relevant literature?

Beyond action

  • How has your understanding of managing infections in people with poorly-controlled HIV evolved since undertaking this DTA and gaining further experience?
  • How have you applied the skills and knowledge gained from this DTA regarding test selection, interpretation, and advice drafting for HIV patients to other immunosuppressed patient groups or specific HIV-related infection scenarios?
  • What connections can you draw between this DTA and other training activities or clinical experiences, such as attending relevant clinics or interpreting HIV aetiology, and how do they build towards your overall development as a Healthcare Scientist dealing with viral infections and immunosuppression?
  • What further development needs related to infections in poorly-controlled HIV patients have been identified through revisiting this experience, and what actions will you now take?

Relevant learning outcomes

# Outcome
# 1 Outcome

Identify appropriate investigative strategies to diagnose and manage infections associated with specialist patient groups, considering guidance and public health requirements

# 2 Outcome

Select tests to diagnose and manage infections and interpret the results in the clinical context for specialist patient groups, with consideration of laboratory quality assurance and quality control

# 3 Outcome

Develop plans and provide advice on infection management for specialist patient groups considering infection control, guidelines and public health requirements